Term of Reference (ToR)

POST GRADUATE COURSE

Tema umum : The role of interferon in the management of Hepatitis B infection

Tujuan : memberikan pemahaman secara utuh kepada peserta tentang peranan interferon

dalam penatalaksaan infeksi virus hepatitis B

TOPIK DAN PEMBICARA

ISI MATERI YANG DIHARAPKAN

Session-1: Basic Immunopathology of Viral  Infection

Moderator: dr. Supriono, SpPD-KGEH

Immunity and Immunopathology to Viruses

Prof. Dr. dr. Handono Kalim, SpPD-KR

(Waktu 30 menit)

Membahas imunitas dan imunopatologi virus secara umum, diantaranya:

‒      Imunologi dasar akibat infeksi virus

‒      Signaling replikasi virus

‒      Sistem imun terhadap virus secara umun:

-       Innate immunity

-       Adaptive immunity

-        Cellular

-        humoral

‒      Interferon and other cytokines

‒      Perkembangan respon imun mulai bayi baru lahir sampai dewasa

‒      Strategi virus dalam menghindari respon imun sehingga dapat menyebabkan virus persisten dan menjadi infeksi kronik

‒      Mekanisme kerusakan jaringan akibat infeksi virus.

-       Faktor2 yang menghambat dan memperberat kerusakan jaringan

Virology and mechanism of seromarkers  in HBV Infection

Prof. Dr. dr. David Handojo Muljono, SpPD, PhD

(Waktu 30 menit)

Membahas virologi virus hepatitis B dan mekanisme terjadinya seromarker akibat infeksi virus hepatitis B, antara lain :

‒    Struktur  virus Hepatitis B, genotip

‒    Siklus hidup hepatitis

‒    Patogenesa infeksi virus hepatitis B

-        Infeksi Hepatitis B akut

-        Infeksi Hepatitis B kronik, fase2 hepatitis B kronik

‒    Mekanisme terbentuknya marker2 akibat infeksi virus hepatitis B (HbsAg, HbsAb, HbeAg, HbeAb, HbxAg, HBV DNA, cccDNA)

‒    Mekanisme kerusakan jaringan hati akibat infeksi virus hepatitis B, apoptosis hepatosit dan reaksi lanjut yang terkait

-          Faktor2 yang menghambat dan memperberat kerusakan hati

Session-2:  Immunoregulation of Hepatitis B Virus Infection

Moderator: dr. Titong Sugihartono, SpPD-KGEH

Possible immuno-modulating the innate immune response in hepatitis B virus infection

Dr. dr. Hery Djagat Purnomo, SpPD-KGEH

(Waktu 30 menit)

Membahas khusus respon imun innate terhadap infeksi virus hepatitis B  dan peluang2 terapinya, antara lain:

‒    Innate immune responses in HBV infection

‒    The Role of Innate Immunity in Control of HBV Infection

-      HBV: a ‘stealth virus’?

-      Role of NK cells in HBV infection

‒    Viral strategies to counteract innate immune responses

/HBV Evasion of the Innate Immune Responses

‒    Innate Immunomodulatory Strategies for the Treatment of HBV Infection

-      Pattern Recognition Receptors (PRR) ligands and adaptors

-      IFN-based inhibition of HBV infection

‒    Further immunotherapeutic approaches based on innate immune responses

Immuno-therapeutic approaches based on adaptive immune responses during chronic HBV infection

Dr. dr. C. Rinaldi A. Lesmana, SpPD-KGEH, FACP

(Waktu 30 menit)

Membahas khusus respon imun adaptive terhadap infeksi virus hepatitis B  dan peluang2 terapinya, antara lain:

‒    Pattern of adaptive immunity in hepatitis B virus infection

‒    Adaptive Immune Responses Against HBV

-          Cellular response : role of CD4+ T and CD8+-cells

-          Humoral response

‒    Mechanisms of HBV evade from adaptive immune response

‒    Immunotherapeutic approaches based on adaptive immune responses

Session-3: Immunotherapy of HBV infection

Moderator: dr. IGA Suryadarma, SpPD-KGEH

Immunotherapy of Hepatitis B Virus Infection –Rationale and Clinical Application

dr. Poernomo Boedi Setiawan, Sp.PD-KGEH

(Waktu 30 menit)

Membahas Imunoterapi terhadap infeksi Hepatitis B kronis secara rasional yang kemungkinan dapat diaplikasikan dalam praktek sehari2, antara lain:

‒    Alteration of immune response during chronic HBV infection

‒    Prophylactic HBsAg vaccines for therapeutic vaccination

‒    Combining antiviral drugs to vaccination

‒    Interferon terapi terhadap infeksi HBV secara umum, mulai dari IFN monoterapi sampai pegylated IFN

‒    Terapi dengan target cccDNA

Immune Therapeutic Strategies in Chronic Hepatitis B Virus Infection: Virus or Inflammation Control?

Prof. dr. Laurentius A. Lesmana, Ph.D, SpPD-KGEH, FACP, FACG

(Waktu 30 menit)

Membahas perbedaan antara penekanan jumlah virus dan proses inflamasi, antara lain:

‒    Respon imun yang terjadi baik akibat:

-      Pengontrolan jumlah virus.  

-      Pengobatan terhadap proses inflamasi.

‒    Pros and cons of finite and infinite therapy strategy

‒    Patients selection for virus or inflammation control

Session-4: interferon based therapy for Chronic Hepatitis B

Moderator: dr. Hariadi Moeljosoedirdjo, SpPD-KGEH

Interferon-Based Therapy for Chronic Hepatitis B infection  

dr. Irsan Hasan, SpPD-KGEH

(Waktu 30 menit)

Membahas peran interferon dalam pengobatan HBV, antara lain:

‒    The importance of Immune Control in chronic Hepatitis B

‒    Pegylated Interferon therapy for Chronic Hepatitis B infection

‒    Response Guided Therapy

‒    Effective adverse event management

The Role of HBsAg Quantification in the Monitoring and Predicting Outcome of Chronic Hepatitis B Management

Prof. Dr. dr. I  Dewa Nyoman Wibawa, SpPD-KGEH

(Waktu 30 menit)

Membahas peran monitoring dan prediksi hasil pengobatan interferon, antara lain:

‒    Monitoring pengobatan HBV secara umum

‒    Mekanisme terbentuknya kuantitatif HbsAg

‒    Evidence base hubungan HbsAg dengan cccDNA

‒    Strategi2 untuk meningkatkan hasil pengobatan HBV

‒    Peran kuantitatif HbsAg untuk monitoring pengobatan HBV

‒    Peran kuantitatif HbsAg sebagai prediksi hasil pengobatan HBV